Is TUDCA Safe? Dosage, Side Effects and Cautions

TUDCA supplements

Written and medically reviewed by Dr Zeeshan Afzal, MBBS — Medical Content Lead, Welzo. Last updated: August 2026.

TUDCA (tauroursodeoxycholic acid) has moved out of hospital pharmacies and into the mainstream gut health aisle, and the question people ask before buying it is a sensible one: what are the TUDCA side effects, and is it actually safe to take every day? The short answer is that TUDCA is generally well tolerated in the studies we have, that reported side effects are overwhelmingly digestive and mild, and that the real question mark is long-term safety data rather than short-term harm. This guide covers the evidence, sensible dosing, and when TUDCA is a bad idea — including how it sits alongside other options such as Welzo Ultra Purity TUDCA, Welzo Ultra Purity Berberine, probiotics, Akkermansia and citrus pectin powder. If this area is new to you, our complete guide to gut health in the UK is the best place to start, and TUDCA vs milk thistle compares it directly with the other popular liver-support supplement.

Key takeaways

  • The most frequently reported TUDCA side effects are digestive: diarrhoea, looser stools, nausea, wind and mild abdominal cramping.
  • In published studies these effects have generally been mild and infrequent, and they usually settle when the dose is lowered or stopped.
  • Human research has used doses from roughly 250 mg to 2,000 mg a day. Most UK food supplements sit at the lower end, typically 200–500 mg.
  • There is no established tolerable upper intake level for TUDCA, and long-term safety data in healthy adults is limited.
  • Avoid TUDCA in pregnancy and breastfeeding, and if you have a blocked bile duct or acute gallbladder inflammation.
  • Speak to a doctor first if you have liver disease, gallstones or inflammatory bowel disease, or take ciclosporin, ciprofloxacin, dapsone, nitrendipine, colestyramine or aluminium-containing antacids.

Table of contents

What is TUDCA and why do people take it?

TUDCA is a bile acid. Your liver makes bile acids from cholesterol, conjugates them with either glycine or taurine, and releases them into the small intestine to help you absorb fat and fat-soluble vitamins. TUDCA is the taurine-conjugated form of ursodeoxycholic acid (UDCA), and it occurs naturally in human bile in very small quantities.

Chemical structure of tauroursodeoxycholic acid (TUDCA) showing the bile acid steroid backbone joined to a taurine side chain

Chemical structure of tauroursodeoxycholic acid. Image: Wikimedia Commons, public domain.

How TUDCA differs from UDCA

This distinction matters for any safety discussion, because most of what we know about bile acid tolerability comes from UDCA rather than TUDCA. UDCA is a licensed prescription medicine in the UK, used for primary biliary cholangitis and for dissolving certain gallstones. TUDCA is the same molecule with a taurine group attached, which makes it more water-soluble and better absorbed.

Once swallowed, TUDCA does not stay as TUDCA. Research using gas chromatography–mass spectrometry in people with primary biliary cholangitis showed that orally administered TUDCA is substantially deconjugated and reconjugated as it recirculates between the gut and the liver, appearing in bile as both glycine- and taurine-conjugated ursodeoxycholate.1 In practical terms, taking TUDCA enriches your bile acid pool with ursodeoxycholate — which is why UDCA safety data is a reasonable, if imperfect, proxy.

Why people take TUDCA as a supplement

Interest has come from three directions. First, liver support: bile acids that are less detergent-like appear to displace harsher endogenous bile acids. Second, metabolic health, after a small randomised trial found improvements in liver and muscle insulin sensitivity. Third, the "chemical chaperone" idea, in which TUDCA reduces endoplasmic reticulum stress inside cells, which drove a decade of neurological research.

It is worth being straight about where that third strand ended up. A large European phase 3 trial of TUDCA in motor neurone disease did not meet its primary endpoint, and no significant differences were found in survival or biomarkers.2 Separately, a combination product containing taurursodiol (another name for TUDCA) plus sodium phenylbutyrate was voluntarily withdrawn from the US market after its confirmatory phase 3 trial failed, and its approval was formally withdrawn.3 Neither was a safety failure — both were efficacy failures — but they are a useful reminder that a promising mechanism does not guarantee a real-world result.

Where TUDCA fits in a wider gut routine

Bile flow and gut function are closely linked. Bile acids shape which bacteria thrive in the small intestine, influence stool consistency, and interact with the gut barrier. People often reach for TUDCA at the same time as other digestive supports such as digestive bitters, betaine HCl or probiotics. Stacking several new products at once is the fastest way to end up unable to tell what caused a side effect.

TUDCA side effects: what the evidence actually shows

Common TUDCA side effects

Across bile acid research, the side effects that come up repeatedly are gastrointestinal, and they follow logically from what bile acids do. Adding bile acid to the intestine draws water into the bowel and speeds transit.

Diarrhoea and looser stools

This is the single most consistently reported effect. In the six-month dose-response study of TUDCA in primary biliary cholangitis, diarrhoea was described as the only side effect observed across the 500 mg, 1,000 mg and 1,500 mg daily groups.4 A systematic review of adverse effects with the parent compound UDCA similarly concluded that it caused diarrhoea in a small proportion of patients.5 If you want a neutral way to judge whether your stools have genuinely changed, the Bristol stool chart is more reliable than memory.

Nausea, cramping and wind

Mild nausea, abdominal discomfort and flatulence appear across bile acid trial documentation, typically at low single-digit percentages, and most often in the first few days of use or when TUDCA is taken on an empty stomach. Some people notice more trapped wind or a sensation of fullness rather than frank pain.

Reduced appetite and mild indigestion

Less frequently, people report appetite suppression or reflux-like indigestion. If reflux is already an issue for you, it is worth reading about supplements for acid reflux before adding anything new.

Less commonly reported side effects

Trial and protocol documentation for TUDCA and UDCA also lists constipation, vomiting, headache, rash and itching, generally at frequencies below one per cent. Fatigue has been reported but is hard to attribute, because the conditions being studied cause fatigue in their own right.

Rare, uncertain and theoretical concerns

Anatomical illustration of the underside of the human liver showing the gallbladder, hepatic ducts and common bile duct

The liver and gallbladder, showing the bile ducts that TUDCA acts on. Image: Gray's Anatomy via Wikimedia Commons, public domain.

Changes in liver blood tests

This is the concern people worry about most, and it deserves a careful answer. The US National Institutes of Health LiverTox database notes that ursodiol has been linked to rare instances of transient and mild elevations in serum aminotransferases, and to rare instances of jaundice and worsening of liver disease in people who already have cirrhosis.6 That last point is the important one: the risk is concentrated in advanced pre-existing liver disease, not in healthy adults. Notably, in the TUDCA dose-response research in primary biliary cholangitis, liver enzyme levels actually fell after the first month of treatment at all three doses.4

If you want a baseline before starting anything that touches liver metabolism, a gut health blood test that includes liver function is a reasonable, low-effort step.

Bile acid metabolism and lithocholic acid

Gut bacteria convert some ursodeoxycholate into lithocholic acid, a more hydrophobic bile acid that is toxic to liver cells in animal models. In humans the liver sulphates lithocholic acid efficiently, which is why this has not translated into meaningful clinical harm at therapeutic doses. The LiverTox overview of bile acids sets out how sharply the safety profiles of different bile acids diverge, with ursodeoxycholic acid the least hepatotoxic of the group.7 It remains a good reason not to assume more is better.

What we do not know

The honest limitation is duration. Most TUDCA studies ran for weeks to months, in people with a specific diagnosis, under supervision. There is no established tolerable upper intake level for TUDCA and no long-term cohort data in healthy adults taking it daily for years. Absence of reported harm is not the same as demonstrated long-term safety.

How common are TUDCA side effects?

The table below groups the side effects reported in the human literature by how often they appear. Study sizes are small, which is itself part of the answer.

How often reported Side effects What usually helps
Most commonly reported Diarrhoea, looser stools, nausea, wind and bloating, mild abdominal cramping Lower the dose, take with food, split into two smaller doses
Less commonly reported Constipation, vomiting, headache, skin rash, itching, reduced appetite Stop and reassess; seek advice if a rash spreads
Rare, uncertain or theoretical Mild changes in liver blood tests, worsening of advanced liver disease, right upper abdominal pain, altered absorption of other medicines Stop and speak to a doctor; separate from binding medicines by 2 hours

The table below summarises the human studies most often cited on TUDCA tolerability.

Study population Daily dose Duration Tolerability reported
Primary biliary cholangitis (dose-response) 500, 1,000 or 1,500 mg 6 months Diarrhoea was the only side effect reported
Primary biliary cholangitis (metabolism study) 500, 1,000 or 1,500 mg 6 months No safety signal reported; bile acid pool shifted as expected
Obese adults with insulin resistance 1,750 mg 4 weeks Treatment completed; liver and muscle insulin sensitivity improved
Motor neurone disease (phase 3, add-on to riluzole) 2,000 mg 18 months Well tolerated; predominantly mild gastrointestinal events in both arms

Are TUDCA side effects dose-dependent?

Broadly, yes — and this is the most useful practical fact in the whole article. Digestive side effects from bile acids track with how much unabsorbed bile acid reaches the colon. Lower doses, taken with food, produce fewer complaints. If you have loose stools on 1,000 mg, halving the dose is far more likely to fix it than persevering.

TUDCA dosage: what has been studied in humans

Context Daily dose used Notes
Chronic hepatitis research 250–1,000 mg Multicentre dose-response design
Primary biliary cholangitis 500–1,500 mg Roughly 10 mg/kg/day suggested for long-term study
Insulin sensitivity research 1,750 mg 4 weeks, small randomised trial
Motor neurone disease trials 2,000 mg (1 g twice daily) 18 months, close clinical supervision
Typical UK food supplement 200–500 mg Some products go to 1,000 mg

Doses used in liver research

Studies in primary biliary cholangitis compared 500 mg, 1,000 mg and 1,500 mg daily over six months. Liver enzymes improved significantly at all three doses within the first month, with no significant difference between them, which led the investigators to suggest around 10 mg per kilogram of body weight per day for long-term study.4 For a 70 kg adult that is roughly 700 mg a day. A separate multicentre study in chronic hepatitis used 250 mg, 500 mg and 1,000 mg daily.

Doses used in metabolic research

The frequently cited randomised study in obese, insulin-resistant adults used 1,750 mg daily for four weeks and reported roughly a 30% improvement in hepatic and muscle insulin sensitivity, without a corresponding change in adipose tissue.8 It is a small study, and it is the origin of a great deal of online enthusiasm about TUDCA and blood sugar. If metabolic health is your reason for considering it, our overview of gut health and blood sugar gives useful context, and berberine vs metformin covers a better-evidenced alternative.

Doses used in neurological trials

The European phase 3 trial in motor neurone disease used 1 g twice daily — 2,000 mg — alongside riluzole for 18 months, and reported that treatment was well tolerated with predominantly mild gastrointestinal adverse events in both the treatment and placebo arms.2 That is the highest routinely used dose in the literature, given under close supervision to people with a serious diagnosis.

Typical UK supplement doses

Most UK TUDCA capsules provide between 200 mg and 500 mg per serving, with some going to 1,000 mg. There is no officially recommended intake, no reference nutrient intake, and no established upper limit. A conservative approach is to start at the lowest dose on the label, take it with food, and hold there for at least two to four weeks before considering any change. Welzo Ultra Purity TUDCA states its per-capsule dose clearly for exactly this reason.

Should TUDCA be taken with food?

Taking TUDCA with a meal containing some fat is the most commonly suggested approach, and it makes physiological sense: bile is released in response to food, so the supplement joins a process already underway rather than arriving into an empty intestine. Anecdotally this also reduces nausea. There is no strong evidence favouring a particular time of day.

How to reduce the risk of side effects

  1. Start low. Begin at the bottom of the label range rather than the top.
  2. Take it with food, ideally a meal containing some fat.
  3. Split larger doses. Two smaller doses are usually gentler than one large one.
  4. Change one thing at a time. If you start a probiotic, a prebiotic and a digestive enzyme in the same week, you will not know what caused what.
  5. Separate it from binding medicines. Leave at least two hours between TUDCA and colestyramine, colestipol, activated charcoal or aluminium-containing antacids.
  6. Track symptoms. A simple two-week note of stool form, timing and dose is more informative than any online forum.
  7. Reassess. If nothing has changed after eight to twelve weeks, stopping is a legitimate decision.

Who should avoid TUDCA

Diagram of the gallbladder, cystic duct, common hepatic duct and common bile duct, the structures affected by bile duct obstruction

The gallbladder and bile ducts. Obstruction anywhere along this route is a reason to avoid bile acid supplements. Image: Gray's Anatomy via Wikimedia Commons, public domain.

Avoid TUDCA Speak to a doctor first
Pregnancy Any diagnosed liver condition
Breastfeeding Gallstones or past gallbladder pain
Trying to conceive Gallbladder removed
Known bile duct obstruction Crohn's disease or ulcerative colitis
Acute gallbladder inflammation Bile acid malabsorption
Children, unless a specialist advises Taking ciclosporin, ciprofloxacin, dapsone or nitrendipine
Previous reaction to a bile acid medicine Taking colestyramine, colestipol or aluminium antacids
Decompensated liver disease Taking diabetes medication

Pregnancy and breastfeeding

Avoid. Although UDCA has been used in pregnancy under specialist supervision for obstetric cholestasis, that is a supervised prescription decision, and no dedicated safety studies exist for TUDCA in pregnancy or lactation. UK prescribing information for ursodeoxycholic acid notes that human data in pregnancy is limited and that it should not be used unless clearly necessary.9 If you are pregnant and thinking about digestive supplements, our guide to probiotics in pregnancy covers what is and is not established.

Bile duct obstruction and acute gallbladder inflammation

Avoid. Increasing bile acid flow when the outflow is blocked is the wrong direction of travel. Acute inflammation of the gallbladder or bile ducts, and calcified gallstones, are standard exclusions in bile acid research.

Existing liver disease

Do not self-prescribe. TUDCA is not a substitute for treatment, and the LiverTox entry for ursodiol specifically flags rare worsening of liver disease in people with pre-existing cirrhosis.6 If you have a diagnosed liver condition, this is a conversation with your hepatology team, not a supplement decision.

Gallstones and gallbladder removal

Anatomical illustration of the human gallbladder and cystic duct, the site where gallstones form

The gallbladder, where cholesterol gallstones form. Image: Gray's Anatomy via Wikimedia Commons, public domain.

Speak to a doctor first. Gallstones affect roughly one in ten UK adults, and most cause no symptoms at all.10 Bile acids are used medically to dissolve certain cholesterol stones, but only specific stone types respond, and taking a supplement is not the same as supervised treatment. If your gallbladder has been removed, bile drips continuously rather than being released in a bolus, and adding bile acid can produce loose stools. Our article on bile acid malabsorption explains why.

Inflammatory bowel disease

Speak to a doctor first. Crohn's disease and ulcerative colitis alter the enterohepatic circulation of bile acids, and ileal Crohn's in particular impairs bile acid reabsorption. See our guides to the Crohn's diet and the ulcerative colitis diet.

Children

Avoid unless a specialist has advised it. There is no paediatric dosing evidence for TUDCA as a supplement. For under-18s, children's probiotics are a far better-studied category.

TUDCA drug interactions

Because TUDCA converts largely into ursodeoxycholate in the body, the interaction profile documented for prescription UDCA is the most sensible guide. UK Summaries of Product Characteristics for ursodeoxycholic acid describe the following.9

Medicine or class Nature of the interaction Practical step
Colestyramine, colestipol, activated charcoal Bind bile acids in the intestine and reduce absorption Separate by at least 2 hours
Aluminium hydroxide or smectite antacids Bind bile acids and reduce absorption Separate by at least 2 hours
Ciclosporin Absorption of ciclosporin can be affected Blood levels monitored by the prescriber
Ciprofloxacin Absorption can be reduced in isolated cases Discuss timing with a pharmacist
Nitrendipine, dapsone Metabolic interaction via CYP3A Medical review before combining
Rosuvastatin Slightly raised plasma levels in a healthy-volunteer study Clinical relevance unclear; mention it to your GP
Oestrogens, oral contraceptives, clofibrate Increase hepatic cholesterol secretion, counteracting gallstone dissolution Relevant if bile acids are being used for stones
Insulin and diabetes medication Theoretical additive effect on insulin sensitivity Monitor blood glucose; discuss with your diabetes team

Two further points. Long-term acid suppression changes the digestive environment in ways that interact with bile and bacteria — see long-term effects of omeprazole. And if you already take berberine, read berberine interactions before stacking.

TUDCA, bile and gut symptoms

Labelled diagram of the human digestive system showing the liver, gallbladder, bile duct, pancreas, small intestine and colon

Bile travels from the liver and gallbladder into the small intestine; whatever is not reabsorbed reaches the colon. Image: Mariana Ruiz via Wikimedia Commons, public domain.

Why bile acids cause loose stools

Bile acids are absorbed at the end of the small intestine and returned to the liver. Whatever is not reabsorbed passes into the colon, where it stimulates fluid secretion and motility. That mechanism is exactly why bile acid malabsorption causes chronic diarrhoea, and it is the same mechanism behind TUDCA's most common side effect. This is not a sign of "detoxing" — it is a straightforward pharmacological effect, and it is dose-related.

How TUDCA differs from gut supplements you may already take

TUDCA acts on bile flow and liver cells. It is not a probiotic, and it does not add bacteria or feed existing ones. If your goal is microbiome diversity, short-chain fatty acid production or correcting gut dysbiosis, then probiotics, Akkermansia, citrus pectin and dietary fibre address the question directly, whereas TUDCA does not.

If bloating is your main symptom

TUDCA is rarely the right first answer for bloating. Start with the more common causes covered in foods that cause bloating and the best supplements for bloating.

Quality and purity: the other half of safety

For an unlicensed supplement, product quality is a genuine safety variable rather than a marketing angle. TUDCA is sold as a food supplement in the UK, which means it is not assessed for efficacy the way a licensed medicine is.

What to look for on the label

  • The exact milligrams of TUDCA per capsule, not per "serving" of unspecified size.
  • Stated purity, ideally 98% or higher, with a certificate of analysis available.
  • Third-party or independent batch testing for heavy metals and microbial contamination.
  • A UK or EU address for the responsible food business operator.
  • No vague proprietary blends that hide the actual dose.

Be sceptical of health claims

No supplement sold in the UK may lawfully claim to treat, cure or prevent disease. If a TUDCA product is marketed as a liver treatment, a hangover cure or a fix for fatty liver, that tells you something about the seller rather than the ingredient. It is also a reasonable reason to look elsewhere in the gut health range.

When to stop TUDCA and see a doctor

Stop taking TUDCA and seek medical advice promptly if you develop any of the following:

  • Yellowing of the skin or the whites of the eyes (jaundice)
  • Dark urine or pale, clay-coloured stools
  • Severe or persistent pain in the upper right side of your abdomen
  • Persistent vomiting, or diarrhoea lasting more than a few days
  • Widespread rash, swelling of the face or lips, or difficulty breathing
  • Unexplained fever alongside abdominal pain

Our guide on when to see a GP about stomach problems covers the wider red flags. It is also worth knowing that a persistent change in bowel habit should never be assumed to be a supplement side effect without being checked — see bowel cancer screening in the UK.

Suspected side effects from supplements as well as medicines can be reported to the MHRA through the Yellow Card scheme.

The verdict: is TUDCA safe?

On the evidence available, TUDCA appears to be well tolerated by most adults at the doses used in research, with side effects that are predominantly digestive, mild and reversible. In the largest and longest trial to date — 18 months at 2,000 mg daily in people with a serious neurological condition — tolerability was reported as good, with mild gastrointestinal events occurring in both the treatment and placebo groups.2

Three caveats keep this from being an unqualified endorsement. There is no established upper intake level. There is no long-term safety data in healthy adults using it daily. And the efficacy case in healthy people is much weaker than the marketing suggests, given that the highest-profile clinical programmes involving TUDCA have not delivered on their primary endpoints. "Probably safe short-term" and "worth taking" are different questions, and the second currently has a thinner answer than the first.

If you decide to try it, start low, take it with food, change one variable at a time, and check with your GP or pharmacist first if you take prescription medication or have any liver, gallbladder or bowel condition.

Frequently asked questions

What are the most common TUDCA side effects?

Digestive symptoms are the most common: diarrhoea or looser stools, nausea, wind, bloating and mild abdominal cramping. In published studies these have generally been mild, infrequent and reversible. Diarrhoea was the only side effect reported in the six-month dose-response study of TUDCA in primary biliary cholangitis.

Is TUDCA bad for your liver?

There is no good evidence that TUDCA harms the liver in healthy adults, and in liver disease research liver enzymes generally improved rather than worsened. The exception is people who already have advanced liver disease: the NIH LiverTox database records rare instances of jaundice and worsening liver disease with ursodiol in people with pre-existing cirrhosis. If you have a diagnosed liver condition, TUDCA is a decision for your specialist.

How much TUDCA is safe to take per day?

There is no officially established safe upper limit. Human studies have used 250 mg to 2,000 mg daily, most commonly 500–1,500 mg, with 2,000 mg used in supervised trials. Most UK supplements provide 200–500 mg. Starting at the lowest labelled dose, taken with food, is the sensible approach.

Can you take TUDCA every day long-term?

Studies have run for up to 18 months without new safety signals, but there is no long-term data in healthy adults taking TUDCA as a daily supplement for years. Many people use it for defined periods of eight to twelve weeks and then reassess, which is reasonable given the evidence gap.

Does TUDCA cause diarrhoea?

It can. Bile acids that are not reabsorbed in the small intestine draw water into the colon and speed transit, which loosens stools. This is dose-related, so reducing the dose and taking it with food usually resolves it. If diarrhoea persists for more than a few days after stopping, see your GP.

Should you take TUDCA with or without food?

With food, ideally a meal containing some fat. Bile is released in response to eating, so taking TUDCA alongside a meal fits the body's normal rhythm and tends to reduce nausea and cramping compared with taking it on an empty stomach.

Who should not take TUDCA?

Avoid TUDCA if you are pregnant, breastfeeding or trying to conceive, if you have a known bile duct obstruction or acute gallbladder inflammation, if you have decompensated liver disease, or if you have previously reacted to a bile acid medicine. Children should not take it unless a specialist advises. Anyone with liver disease, gallstones, inflammatory bowel disease or bile acid malabsorption, or who takes ciclosporin, ciprofloxacin, dapsone, nitrendipine, colestyramine or aluminium-based antacids, should speak to a doctor first.

Does TUDCA interact with medications?

Yes, based on the interaction profile documented for prescription ursodeoxycholic acid. Bile acid binders such as colestyramine and colestipol, and aluminium-containing antacids, reduce absorption and should be separated by at least two hours. Absorption of ciclosporin and ciprofloxacin can be affected, and metabolic interactions have been described with nitrendipine and dapsone. Check with a pharmacist if you take any regular medication.

Is TUDCA legal and regulated in the UK?

TUDCA is sold in the UK as a food supplement, not a licensed medicine. That means it is not assessed for efficacy the way a prescription drug is, and no product may lawfully claim to treat or cure disease. Its close relative ursodeoxycholic acid is a prescription-only medicine. Because supplement quality varies, look for stated purity, batch testing and a clear per-capsule dose.

Is TUDCA better than milk thistle for liver support?

They are not directly comparable, and neither has strong evidence for liver support in healthy adults. TUDCA acts on bile acid composition and bile flow, with most human data coming from people with diagnosed cholestatic liver disease. Milk thistle (silymarin) is an antioxidant plant extract with mixed trial results. Our TUDCA vs milk thistle comparison covers the evidence for each in detail.

References

  1. Setchell KD, Rodrigues CM, Podda M, Crosignani A. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut. 1996;38(3):439–46. PubMed
  2. MND Association. Tauroursodeoxycholic acid (TUDCA) — phase 3 clinical trial results. mndassociation.org. Trial registration: ClinicalTrials.gov NCT03800524
  3. US Food and Drug Administration / Federal Register. Withdrawal of approval of the new drug application for sodium phenylbutyrate and taurursodiol following the phase 3 PHOENIX trial. federalregister.gov
  4. Crosignani A, Battezzati PM, Setchell KD, et al. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis: a dose-response study. Digestive Diseases and Sciences. 1996;41(4):809–15. PubMed
  5. Hempfling W, Dilger K, Beuers U. Ursodeoxycholic acid — adverse effects and drug interactions. Alimentary Pharmacology & Therapeutics. 2003;18(10):963–72. Wiley Online Library
  6. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Ursodiol (ursodeoxycholic acid). National Institute of Diabetes and Digestive and Kidney Diseases. NCBI Bookshelf
  7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bile acids. National Institute of Diabetes and Digestive and Kidney Diseases. NCBI Bookshelf
  8. Kars M, Yang L, Gregor MF, et al. Tauroursodeoxycholic acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes. 2010;59(8):1899–905. American Diabetes Association
  9. Ursodeoxycholic acid 250 mg capsules — Summary of Product Characteristics. Electronic Medicines Compendium (emc). medicines.org.uk
  10. NHS. Gallstones. nhs.uk
  11. Ursodeoxycholic acid. StatPearls. NCBI Bookshelf, National Library of Medicine. NCBI Bookshelf
  12. Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: the TUDCA-ALS trial protocol. Frontiers in Neurology. PubMed Central
  13. Examine.com. TUDCA: benefits, dosage and side effects — independent evidence summary. examine.com
  14. Medicines and Healthcare products Regulatory Agency. Yellow Card scheme for reporting suspected side effects. yellowcard.mhra.gov.uk

About the author

Dr Zeeshan Afzal, MBBS is a practising doctor and Medical Content Lead at Welzo, where he reviews clinical content for accuracy and alignment with UK guidance. This article was researched using peer-reviewed clinical trials, the NIH LiverTox database, UK Summaries of Product Characteristics and NHS guidance.

Medical disclaimer

This article is for general information only and does not constitute medical advice, diagnosis or treatment. TUDCA is sold as a food supplement and is not a licensed medicine in the UK. It is not intended to treat, cure or prevent any disease. Always speak to your GP, pharmacist or specialist before starting a new supplement, particularly if you are pregnant or breastfeeding, take prescription medication, or have a liver, gallbladder or bowel condition. If you develop jaundice, severe abdominal pain or persistent vomiting, seek medical attention promptly.

Image credits

All images used in this article are in the public domain and are free of copyright restrictions. Chemical structure of tauroursodeoxycholic acid, and anatomical plates of the liver, gallbladder and bile ducts from Gray's Anatomy, via Wikimedia Commons. Digestive system diagram by Mariana Ruiz Villarreal, released into the public domain, via Wikimedia Commons.

Related products

Welzo Ultra Purity Energy & Focus Stack — NMN + PQQ + TMG
Welzo Ultra Purity
Welzo Ultra Purity Energy & Focus...
114 Recenzije
€66,95
Add to Cart
Welzo Ultra Purity Energy & Focus Stack — NMN + PQQ + TMG
Welzo Ultra Purity
Welzo Ultra Purity Energy & Focus...
114 Recenzije
€69,95
Add to Cart
Welzo Ultra Purity TUDCA
Welzo Ultra Purity
Welzo Ultra Purity TUDCA
48 Recenzije
€27,95
Add to Cart